首页> 外文期刊>Transplantation Proceedings >Laparoscopic fenestration versus percutaneous catheter drainage for lymphocele treatment after kidney transplantation
【24h】

Laparoscopic fenestration versus percutaneous catheter drainage for lymphocele treatment after kidney transplantation

机译:腹腔镜开窗术与经皮导管引流术治疗肾移植后的淋巴膨出

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Laparoscopic fenestration (LF) and percutaneous catheter drainage (PCD) are widely accepted treatments for symptomatic lymphoceles. The aim of this study was to review the results and compare the outcomes of LF with those of PCD. Patients and Methods: Among 1363 patients who underwent kidney transplantation at our institute between 1999 and 2011, 35 (2.5%) developed symptomatic lymphoceles. Among them, 7 were treated by LF after PCD; 10, LF only, and 18 PCD only. The patients were divided into 2 groups based upon the treatment method: LF (n = 17) and PCD-only groups (n = 18). Results: No intergroup differences in age, gender, diabetes prevalence, retransplant rate, delayed graft function, or serum creatinine was observed at 7 days after the treatment. However, acute rejection episodes and sirolimus use were more frequent among the LF group (P =.028). Furthermore, median drainage on the first day was significantly greater in the LF versus PCD group. After catheter insertion, the PCD group showed a significant decrease in drainage on the following day, but no decrease was observed in the LF group. Conclusions: LF is a safe treatment for symptomatic lymphocele. LF should be held in reserve for treatment failures after PCD. LF seems to be a more reasonable first-line treatment for symptomatic lymphoceles in patients at high risk for graft dysfunction.
机译:背景:腹腔镜开窗术(LF)和经皮导管引流术(PCD)是有症状淋巴囊肿的广泛接受的治疗方法。这项研究的目的是审查结果并将LF与PCD的结果进行比较。患者与方法:在我院1999年至2011年间接受肾脏移植的1363名患者中,有35名(2.5%)出现了症状性淋巴囊肿。其中7例行PCD后行LF治疗。 10,仅LF和18 PCD。根据治疗方法将患者分为2组:LF(n = 17)和仅PCD组(n = 18)。结果:治疗后7天,未观察到年龄,性别,糖尿病患病率,再移植率,移植物功能延迟或血清肌酐的组间差异。但是,LF组中急性排斥反应和西罗莫司的使用更为频繁(P = .028)。此外,LF组与PCD组相比,第一天的中位引流明显增加。插入导管后,PCD组第二天的引流明显减少,而LF组则没有观察到减少。结论:LF是一种有症状的淋巴结肿大的安全治疗方法。对于PCD后的治疗失败,应保留LF。对于有移植功能障碍高风险的患者,对于有症状的淋巴囊肿,LF似乎是一种更合理的一线治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号